Keynote Financial Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.82M Sell
27,243
-1,381
-5% -$123K 1.32% 15
2026
Q1
$2.06M Sell
28,624
-653
-2% -$50.3K 1.09% 19
2025
Q4
$2.32M Sell
29,277
-22
-0.1% -$1.73K 1.3% 15
2025
Q3
$2.21M Sell
29,299
-575
-2% -$39.4K 1.33% 15
2025
Q2
$2.06M Sell
29,874
-2,502
-8% -$164K 1.39% 13
2025
Q1
$2.19M Sell
32,376
-9
-0% -$539 1.57% 13
2024
Q4
$1.45M Buy
32,385
+4,034
+14% +$226K 1.12% 23
2024
Q3
$1.78M Buy
28,351
+3,320
+13% +$194K 1.36% 15
2024
Q2
$1.48M Buy
25,031
+1,168
+5% +$73.1K 1.24% 21
2024
Q1
$1.9M Buy
+23,863
New +$1.82M 1.6% 11

Other funds holding CVS

Keynote Financial Services's CVS Position: Q2 2026 in Review

Keynote Financial Services reduced its CVS Health (CVS) stake by 4.8% in Q2 2026, selling an estimated $123K and leaving 27,243 shares worth $2.82M. The position accounts for 1.32% of the portfolio, ranked #15.

Keynote Financial Services first reported a position in CVS in Q1 2024 and has held it in 10 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Keynote Financial Services held 27,243 shares of CVS Health worth $2.82M as of Q2 2026.
  • Keynote Financial Services sold 1,381 CVS Health shares in Q2 2026, an estimated $123K.
  • CVS Health made up 1.32% of Keynote Financial Services's portfolio in Q2 2026, its #15 holding.
  • Keynote Financial Services first reported a position in CVS Health in Q1 2024 and has held it in 10 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Keynote Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.